serw-MX  [xml]  

 DeCS Categories

A10 Tissues .
C12 Male Urogenital Diseases .
C12.706 Urogenital Abnormalities .
C12.706.316 Disorders of Sex Development .
C12.706.316.343 Ovotesticular Disorders of Sex Development .
C13 Female Urogenital Diseases and Pregnancy Complications .
C13.351 Female Urogenital Diseases .
C13.351.875 Urogenital Abnormalities .
C13.351.875.253 Disorders of Sex Development .
C13.351.875.253.343 Ovotesticular Disorders of Sex Development .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.131 Congenital Abnormalities .
C16.131.939 Urogenital Abnormalities .
C16.131.939.316 Disorders of Sex Development .
C16.131.939.316.343 Ovotesticular Disorders of Sex Development .
C19 Endocrine System Diseases .
C19.391 Gonadal Disorders .
C19.391.119 Disorders of Sex Development .
C19.391.119.343 Ovotesticular Disorders of Sex Development .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.124 Blood Proteins .
D12.776.124.486 Immunoproteins .
D12.776.124.486.485 Immunoglobulins .
D12.776.124.486.485.114 Antibodies .
D12.776.124.486.485.114.125 Antibodies, Bispecific .
D12.776.124.790 Serum Globulins .
D12.776.124.790.651 Immunoglobulins .
D12.776.124.790.651.114 Antibodies .
D12.776.124.790.651.114.134 Antibodies, Bispecific .
D12.776.377 Globulins .
D12.776.377.715 Serum Globulins .
D12.776.377.715.548 Immunoglobulins .
D12.776.377.715.548.114 Antibodies .
D12.776.377.715.548.114.134 Antibodies, Bispecific .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.399 Hormones, Hormone Substitutes, and Hormone Antagonists .
D27.505.696.399.472 Hormones .
D27.505.696.399.472.161 Androgens .
D27.505.696.399.472.277 Estrogens .
D27.505.696.399.472.858 Progestins .
G12 Immune System Phenomena .
G12.450 Immunity .
G12.450.418 Immunity, Heterologous .
M01 Persons .
M01.390 Men 6563 .
M01.390.660 Nurses, Male .
M01.526 Occupational Groups .
M01.526.485 Health Personnel .
M01.526.485.650 Nurses .
M01.526.485.650.670 Nurses, Male .
N02 Health Care Facilities, Manpower, and Services .
N02.360 Health Personnel .
N02.360.650 Nurses .
N02.360.650.670 Nurses, Male .
SP8 Disasters .
SP8.473 Risk 17142 .
SP8.473.654 Hazards .
SP8.473.654.412 Technological Threats .
SP8.473.654.412.052 Substances, Products and Materials .
SP8.473.654.412.052.005 Classification and Identification of Substances, Products and Materials .
SP8.473.654.412.052.005.030 Classification and Identification by Toxicity .
SP8.473.654.412. Target Organs .
 Synonyms & Historicals
Androgens .
Androgen Effect .
Androgen Effects .
Androgen Receptor Agonists .
Androgenic Agents .
Androgenic Compounds .
Agents, Androgenic .
Agonists, Androgen Receptor .
Compounds, Androgenic .
Effect, Androgen .
Effects, Androgen .
Receptor Agonists, Androgen .
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. .
Estrogens .
Estrogen .
Estrogen Effect .
Estrogen Effects .
Estrogen Receptor Agonists .
Estrogenic Agents .
Estrogenic Compounds .
Estrogenic Effect .
Estrogenic Effects .
Agents, Estrogenic .
Agonists, Estrogen Receptor .
Compounds, Estrogenic .
Effects, Estrogen .
Effects, Estrogenic .
Receptor Agonists, Estrogen .
Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. .
Progestins .
Gestagen .
Gestagen Effect .
Gestagen Effects .
Gestagenic Agents .
Gestagenic Effect .
Gestagenic Effects .
Gestagens .
Progestagenic Agents .
Progestagens .
Progestational Agents .
Progestational Compounds .
Progestational Hormones .
Progestin .
Progestin Effect .
Progestin Effects .
Progestogen Effect .
Progestogen Effects .
Effect, Gestagen .
Effect, Gestagenic .
Effect, Progestin .
Effect, Progestogen .
Effects, Gestagen .
Effects, Gestagenic .
Effects, Progestin .
Effects, Progestogen .
Progestogens .
Progestational Hormones .
Progestational Hormone Analogs .
Progestin Analogs .
Progestational Hormones, Synthetic .
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. .
Immunity, Heterologous .
Heterologous Effects of Vaccine .
Heterologous Effects of Vaccines .
Non-Specific Effects of Vaccine .
Non-Specific Effects of Vaccines .
Non-Target Heterologous Effects of Vaccine .
Non-Target Heterologous Effects of Vaccines .
Non-Targeted Immunity .
Off Target Effects of Vaccine .
Off Target Effects of Vaccines .
Immunity, Non-Targeted .
Non Specific Effects of Vaccine .
Non Specific Effects of Vaccines .
Non Target Heterologous Effects of Vaccine .
Non Target Heterologous Effects of Vaccines .
Non Targeted Immunity .
Vaccine Heterologous Effect .
Vaccine Heterologous Effects .
Vaccine Non-Specific Effect .
Vaccine Non-Specific Effects .
Vaccines Heterologous Effect .
Vaccines Heterologous Effects .
Vaccines Non-Specific Effect .
Vaccines Non-Specific Effects .
Heterologous Immunity .
The immunological phenomenon by which exposure to some organisms or vaccines can profoundly alter the host's response to subsequent exposure to unrelated (heterologous) organisms or vaccines. .
Ovotesticular Disorders of Sex Development .
46,XX Gonadal Dysgenesis, Complete, Sry-Positive .
46,XX True Hermaphroditism, Sry-Positive .
Familial True Hermaphroditism .
Familial XX True Hermaphroditism .
Ovotesticular DSD .
Ovotesticular Disorder Of Sex Development .
True Hermaphroditism .
XX Male Syndrome, Sry-Positive .
DSD, Ovotesticular .
DSDs, Ovotesticular .
Familial True Hermaphroditisms .
Hermaphroditism, Familial True .
Hermaphroditisms, Familial True .
Hermaphroditisms, True .
Ovotesticular DSDs .
True Hermaphroditism, Familial .
True Hermaphroditisms .
True Hermaphroditisms, Familial .
XX Male Syndrome, Sry Positive .
Hermaphroditism, True .
Conditions of sexual ambiguity in which the individual possesses gonadal tissues of both sexes, tissues from the OVARY and the TESTIS. There can be a testis on one side and an ovary on the other (lateral), or there may be combined ovarian and testicular tissue (ovotestes) on each side (bilateral). The karyotype may be 46,XX; 46,XY; or a mosaic of 46,XX/46,XY. These disorders have historically been called true hermaphroditism. .
Target Organs .
Nurses, Male .
Male Nurse .
Male Nurses .
Nurse, Male .
Nurses of the male sex. .
Tissues .
Tissue .
Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others. .
Antibodies, Bispecific .
Bispecific Monoclonal Antibodies .
Antibodies, Bifunctional .
Antibodies, Bispecific Monoclonal .
Monoclonal Antibodies, Bispecific .
Bifunctional Antibodies .
Bispecific Antibodies .
Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors. .